Intelligent Mass Spec Solutions develops urine-based mass spectrometry and machine learning diagnostics for adrenal cancer.
INTELLIGENT MASS SPEC SOLUTIONS has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
INTELLIGENT MASS SPEC SOLUTIONS's investors include British Business Bank, SFC Capital, UK Innovation & Science Seed Fund, Midlands Mindforge, NG Bio.
INTELLIGENT MASS SPEC SOLUTIONS is headquartered in Solihull, United Kingdom.
Intelligent Mass Spec Solutions develops urine-based mass spectrometry and machine learning diagnostics for adrenal cancer.
INTELLIGENT MASS SPEC SOLUTIONS is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"INTELLIGENT MASS SPEC SOLUTIONS — Funding & Investors." VCBacked, September 22, 2026, https://www.vcbacked.co/company/intelligent-mass-spec-solutions. Accessed October 1, 2026.
VCBacked. (2026). INTELLIGENT MASS SPEC SOLUTIONS — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/intelligent-mass-spec-solutions
{{cite web |title=INTELLIGENT MASS SPEC SOLUTIONS — Funding & Investors |url=https://www.vcbacked.co/company/intelligent-mass-spec-solutions |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated